Prevalence of Hypertension in Vietnam: A Systematic Review and Meta-Analysis.
Vietnam
awareness
hypertension
meta-analysis
prevalence
systematic review
Journal
Asia-Pacific journal of public health
ISSN: 1941-2479
Titre abrégé: Asia Pac J Public Health
Pays: China
ID NLM: 8708538
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
pubmed:
27
1
2019
medline:
30
1
2020
entrez:
26
1
2019
Statut:
ppublish
Résumé
Studies on the prevalence of hypertension in Vietnam have reported various estimates. There is no up-to-date assessment of the evidence on the magnitude of hypertension in Vietnam. Search engines for scientific and gray literature were used to identify relevant records for eligibility screening and quality assessment. Data from selected articles were extracted using standardized spreadsheets. Statistical analysis included estimating pooled prevalence and odds ratio, heterogeneity evaluation, meta-regression, and subgroup analysis, in addition to sensitivity analysis and publication bias evaluation. The pooled prevalence of measured hypertension in Vietnam was 21.1% (95% confidence interval = 18.5-23.7) based on 10 studies, and 18.4% (95% confidence interval = 15.2-21.8) based on 3 national surveys. Lower pooled prevalence was estimated for hypertension awareness (9.3%) and hypertension treatment (4.7%). The pooled prevalence of measured hypertension is significantly higher among men. The pooled prevalence of measured hypertension and hypertension awareness and treatment were significantly lower in rural settings. There is a need to strengthen efforts for primary and secondary prevention and disease management to reduce morbidity and mortality, especially in rural residence settings.
Identifiants
pubmed: 30678477
doi: 10.1177/1010539518824810
pmc: PMC6463272
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101-112Références
Diabet Med. 2004 Apr;21(4):371-6
pubmed: 15049941
Lancet. 2017 Sep 16;390(10100):1151-1210
pubmed: 28919116
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
BMC Public Health. 2016 Jun 10;16:498
pubmed: 27286818
PLoS One. 2013 Jun 27;8(6):e66792
pubmed: 23826134
J Clin Hypertens (Greenwich). 2016 Jan;18(1):5-6
pubmed: 26646424
Eur J Vasc Endovasc Surg. 2010 Nov;40(5):669-77
pubmed: 20732826
PLoS One. 2013;8(3):e58302
pubmed: 23484011
J Epidemiol Glob Health. 2012 Sep;2(3):155-63
pubmed: 23538875
J Hum Hypertens. 2012 Apr;26(4):268-80
pubmed: 21368775
J Clin Hypertens (Greenwich). 2016 Nov;18(11):1135-1142
pubmed: 27458104
Int J Hypertens. 2012;2012:560397
pubmed: 22500217
Int J Hypertens. 2018 May 16;2018:6326984
pubmed: 29887994
Lancet. 2017 Sep 16;390(10100):1345-1422
pubmed: 28919119
J Nutr Sci Vitaminol (Tokyo). 2001 Apr;47(2):147-55
pubmed: 11508706
Medicine (Baltimore). 2015 Dec;94(50):e1959
pubmed: 26683910
J Am Coll Nutr. 2001 Dec;20(6):616-22
pubmed: 11771677
BMC Public Health. 2017 Apr 5;17(1):298
pubmed: 28381223
BMC Endocr Disord. 2014 Sep 26;14:77
pubmed: 25261978
Eur J Clin Nutr. 2007 May;61(5):673-81
pubmed: 17164831
Value Health Reg Issues. 2014 May;3:87-93
pubmed: 29702943
Am J Hypertens. 2015 Jan;28(1):89-97
pubmed: 24862960
BMC Public Health. 2009 Aug 12;9:291
pubmed: 19671195
J Hum Hypertens. 2006 Feb;20(2):109-15
pubmed: 16195706
Am J Clin Nutr. 2009 Jun;89(6):1905-12
pubmed: 19369374
PLoS One. 2012;7(8):e42825
pubmed: 22912747
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
Glob Health Action. 2009 Sep 28;2:
pubmed: 20027254
Asia Pac J Clin Nutr. 2009;18(2):226-33
pubmed: 19713182
J Hum Hypertens. 2007 Jan;21(1):28-37
pubmed: 17066088
Prev Chronic Dis. 2007 Apr;4(2):A22
pubmed: 17362613
Lancet. 2017 Sep 16;390(10100):1260-1344
pubmed: 28919118
Biomed Res Int. 2018 Oct 9;2018:7814195
pubmed: 30402492
Diabetologia. 2010 Oct;53(10):2139-46
pubmed: 20596691